Logo

JP Morgan Healthcare Conference

Pacific Biosciences Outlines Progress on Short-Read Sequencing at JPM, Partners With Canexia Health

The company presented data on a new cluster generation method it plans to use for its sequencing-by-binding platform, due out next year.

NanoString Technologies Touts Interest in CosMx Spatial Biology Platform at JPM

The Seattle-based company has already sold 20 platforms ahead of the Q4 launch, and researchers are receiving data from the CosMx Technology Access Program.

Quanterix Projects Q4 2021 Revenues of $29M to $31M

The company projected full year 2021 revenues of $109 million to $111 million, up from $86.4 million in 2020.

JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More

Highlights of the third day included Quantum-Si's plans for its protein sequencing platform and strategic initiatives from Opko's BioReference Laboratories. 

Singular Genomics Outlines Launch Plans for G4 Sequencer at JPM

Several early-access customers have already generated data on the G4 sequencer, and the company plans to launch several reagent kits this year.

Jan 12, 2022

Invitae Launches Ciitizen Genome Information Management Platform at JPM

Jan 12, 2022

JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More

Jan 11, 2022

JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4

Jan 11, 2022

Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference

Jan 14, 2021

Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Jan 13, 2021

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Jan 12, 2021

Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Jan 11, 2021

Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan

Jan 11, 2021

PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

Feb 3, 2020

Illumina Stock Drags GenomeWeb Index Down in January

Jan 16, 2020

Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform
Premium

Jan 16, 2020

JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

Jan 15, 2020

JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

Jan 14, 2020

Illumina, Genomics England Ink Deal to Sequence up to 300K People

Jan 14, 2020

Nference Named First Partner for New Mayo Clinical Analytics Platform

Jan 13, 2020

JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics

Breaking News
The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.